Gideon Korrell Breaks Down Eye Therapies v. Slayback Pharma Patent Ruling

In a significant reversal for the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB), the Federal Circuit on June 30, 2025, held that the Board erred in its construction of the transitional claim phrase “consisting essentially of...